Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Raf: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | Raf |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis, Cancer, Dementia |
| Interactions | MITOCHONDRIA, ARF6, REELIN, DYNEIN, DAPK1, APP |
| KG Connections | 1104 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
Raf["Raf"] -->|"expressed in"| Als["Als"]
style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
Raf["Raf"] -->|"expressed in"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
style Amyotrophic_Lateral_Sclerosis fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
Raf["Raf"] -->|"expressed in"| Alzheimer["Alzheimer"]
style Alzheimer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
Raf["Raf"] -->|"regulates"| Ischemia["Ischemia"]
style Ischemia fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
Raf["Raf"] -->|"biomarker for"| Neurodegeneration["Neurodegeneration"]
style Neurodegeneration fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
Raf["Raf"] -->|"biomarker for"| Cancer["Cancer"]
style Cancer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
Raf["Raf"] -->|"biomarker for"| Neuroinflammation["Neuroinflammation"]
style Neuroinflammation fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
TARDBP["TARDBP"] -->|"regulates"| Raf["Raf"]
style TARDBP fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
FTLD["FTLD"] -->|"expressed in"| Raf["Raf"]
style FTLD fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
RNA["RNA"] -->|"regulates"| Raf["Raf"]
style RNA fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
ALS["ALS"] -->|"expressed in"| Raf["Raf"]
style ALS fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
APOE4["APOE4"] -->|"expressed in"| Raf["Raf"]
style APOE4 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style Raf fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Als | expressed_in | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.60 |
| Alzheimer | expressed_in | disease | 0.60 |
| Ischemia | regulates | disease | 0.60 |
| Neurodegeneration | biomarker_for | disease | 0.60 |
| Cancer | biomarker_for | disease | 0.60 |
| Neuroinflammation | biomarker_for | disease | 0.60 |
| Alzheimer | interacts_with | disease | 0.60 |
| Multiple Sclerosis | therapeutic_target | disease | 0.60 |
| Neuroinflammation | therapeutic_target | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Als | transports | disease | 0.60 |
| Als | associated_with | disease | 0.60 |
| Aging | associated_with | disease | 0.60 |
| Aging | expressed_in | disease | 0.60 |
| Parkinson | expressed_in | disease | 0.60 |
| Huntington | expressed_in | disease | 0.60 |
| Cancer | regulates | disease | 0.60 |
| Tauopathy | activates | disease | 0.60 |
| Pyroptosis | therapeutic_target | disease | 0.60 |
| Fibrosis | therapeutic_target | disease | 0.60 |
| Ferroptosis | therapeutic_target | disease | 0.60 |
| Ferroptosis | regulates | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.60 |
| Spinal Muscular Atrophy | associated_with | disease | 0.60 |
| Dementia | associated_with | disease | 0.60 |
| Frontotemporal Dementia | associated_with | disease | 0.60 |
| Multiple Sclerosis | transports | disease | 0.60 |
| Depression | activates | disease | 0.60 |
| Diabetes | associated_with | disease | 0.60 |
| Ferroptosis | activates | disease | 0.60 |
| Necroptosis | activates | disease | 0.60 |
| Aging | interacts_with | disease | 0.60 |
| Als | inhibits | disease | 0.60 |
| Autism | interacts_with | disease | 0.60 |
| Schizophrenia | interacts_with | disease | 0.60 |
| Cancer | expressed_in | disease | 0.60 |
| Parkinson | inhibits | disease | 0.60 |
| Neurodegeneration | inhibits | disease | 0.60 |
| Frontotemporal Dementia | regulates | disease | 0.60 |
| Dementia | regulates | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.60 |
| Neurodegeneration | activates | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | causes | disease | 0.60 |
| Dementia | causes | disease | 0.60 |
| Frontotemporal Dementia | causes | disease | 0.60 |
| Fibrosis | inhibits | disease | 0.60 |
| Ferroptosis | inhibits | disease | 0.60 |
| Senescence | therapeutic_target | disease | 0.60 |
| Addiction | therapeutic_target | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TARDBP | regulates | gene | 0.60 |
| FTLD | expressed_in | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| ALS | expressed_in | gene | 0.60 |
| APOE4 | expressed_in | gene | 0.60 |
| DNA | regulates | gene | 0.60 |
| TDP-43 | regulates | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| NADH | regulates | gene | 0.60 |
| CTSD | regulates | gene | 0.60 |
| MTORC1 | regulates | gene | 0.60 |
| PIK3C3 | regulates | gene | 0.60 |
| CAT | regulates | gene | 0.60 |
| PPARG | regulates | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| MAP1LC3B | regulates | gene | 0.60 |
| SREBF1 | regulates | gene | 0.60 |
| RPS6KB1 | regulates | gene | 0.60 |
| RUBCN | regulates | gene | 0.60 |
| ACTB | regulates | gene | 0.60 |
| SQSTM1 | regulates | gene | 0.60 |
| PPARA | regulates | gene | 0.60 |
| EGFR | regulates | gene | 0.60 |
| RPS6 | regulates | gene | 0.60 |
| ATG | regulates | gene | 0.60 |
| LAMP1 | regulates | gene | 0.60 |
| RAB7A | regulates | gene | 0.60 |
| LRP2 | regulates | gene | 0.60 |
| ATP | regulates | gene | 0.60 |
| PPARGC1A | regulates | gene | 0.60 |
| CPT1A | regulates | gene | 0.60 |
| EIF4EBP1 | regulates | gene | 0.60 |
| ARF6 | interacts_with | gene | 0.60 |
| REELIN | interacts_with | gene | 0.60 |
| BRAF | associated_with | gene | 0.60 |
| OVERVIEW | biomarker_for | gene | 0.60 |
| H3F3A | associated_with | gene | 0.60 |
| CIC | associated_with | gene | 0.60 |
| ATRX | associated_with | gene | 0.60 |
| FUBP1 | associated_with | gene | 0.60 |
| JUN | biomarker_for | gene | 0.60 |
| TERT | associated_with | gene | 0.60 |
| GAIN | biomarker_for | gene | 0.60 |
| P2RY12 | biomarker_for | gene | 0.60 |
| TREM2 | biomarker_for | gene | 0.60 |
| TMEM119 | biomarker_for | gene | 0.60 |
| MICROGLIA | biomarker_for | gene | 0.60 |
| FCRLS | biomarker_for | gene | 0.60 |
| DYNEIN | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Lysosomal Enzyme Trafficking Correction | 0.489 | neurodegeneration | Autophagy-lysosome pathway convergence a |
| TFAM overexpression creates mitochondrial donor-recipient gr | 0.474 | neurodegeneration | Mitochondrial transfer between astrocyte |
| Sphingomyelin Synthase Activators for Raft Remodeling | 0.468 | neurodegeneration | Lipid raft composition changes in synapt |
| APOE-Mediated Synaptic Lipid Raft Stabilization | 0.426 | neurodegeneration | Mechanistic role of APOE in neurodegener |
| Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy | 0.426 | neurodegeneration | Mitochondrial transfer between neurons a |
| Palmitoylation-Targeted BACE1 Trafficking Disruptors | 0.407 | neurodegeneration | Lipid raft composition changes in synapt |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-13 | 1 hypotheses Top: 0.584
cellular neuroscience | 2026-04-12 | 0 hypotheses
neurodegeneration | 2026-04-04 | 0 hypotheses
neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.648
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Designed endocytosis-inducing proteins degrade targets and amplify signals. [PMID:39322662] | Huang B, Abedi M, Ahn G, Coventry B, Sap | Nature | 2025 | 1 |
| Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy t [PMID:37651673] | Deng Z, He M, Hu H, Zhang W, Zhang Y, Ge | Autophagy | 2024 | 1 |
| TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic [PMID:38783142] | Liu H, Zhen C, Xie J, Luo Z, Zeng L, Zha | Nat Cell Biol | 2024 | 1 |
| Collapse of late endosomal pH elicits a rapid Rab7 response via the V-ATPase and [PMID:38578235] | Mulligan RJ, Magaj MM, Digilio L, Redema | J Cell Sci | 2024 | 1 |
| IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases. [PMID:37031050] | Alberini CM | Trends Neurosci | 2023 | 1 |
| Mitochondrial-derived damage-associated molecular patterns amplify neuroinflamma [PMID:35233090] | Lin MM, Liu N, Qin ZH, Wang Y | Acta Pharmacol Sin | 2022 | 1 |
| Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease. [PMID:33803217] | Chang CH, Lin CH, Lane HY | Int J Mol Sci | 2021 | 1 |
| Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic [PMID:33408785] | Zhao M, Wang Y, Li L, Liu S, Wang C, Yua | Theranostics | 2021 | 1 |
| Mitochondrial DNA copy number in human disease: the more the better? [PMID:33314045] | Filograna R, Mennuni M, Alsina D, Larsso | FEBS Lett | 2021 | 1 |
| Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. [PMID:32186434] | Li C, Zhang Y, Liu J, Kang R, Klionsky D | Autophagy | 2021 | 1 |
| Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate rec [PMID:19251056] | Brown J, Jones EY, Forbes BE | Vitam Horm | 2009 | 1 |
| Blocking palmitoyl-transferase activity reduces BACE1 membrane localization and [PMID:23395894] | Unknown | Molecular Neurodegeneration | 0 | |
| Amyloid-β fibrils accumulated in preeclamptic placentas suppress cytotrophoblast [PMID:41558820] | Nishioka K, Ikezaki M, Iwahashi N, Araka | Life Sci Alliance | 2026 | 0 |
| An anti-inflammatory neuroenhancer mitigates amyloid-β pathology to improve Alzh [PMID:41696149] | Fang W, Zhao J, Li L, Wang Y, Xu ZP et a | Mater Today Bio | 2026 | 0 |
| Anti-ASC antibodies alleviate Alzheimer's disease-type pathology in APP/PS1 mice [PMID:41707905] | He L, Xiaopeng Z, Juan D, Yan L | Neuroscience | 2026 | 0 |
| Intranasal administration of neural stem cell-derived extracellular vesicles pre [PMID:41923110] | Natale F, Dellaria A, Nifo Sarrapochiell | Alzheimer's research & therapy | 2026 | 0 |
| Salvianolic acid a inhibits neuroinflammation and ameliorates Alzheimer's diseas [PMID:41930874] | Xiao S, Han Y, Yan J, Wu L, Lin H et al. | Int Immunopharmacol | 2026 | 0 |
| Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzhei [PMID:41946775] | Phemphunananchai K, Waiwut P, Phetcharab | Scientific reports | 2026 | 0 |
| Nano-magnolol enhances the modulatory effects of magnolol on cognitive performan [PMID:41954680] | Youssef B, Ibrahim EA, Moselhy SS, ElShe | Discov Nano | 2026 | 0 |
| BACE-1 inhibitors as potential drug candidates for treatment of Alzheimer's dise [PMID:41966670] | Kaur N, Gupta S, Bansal G, Bansal Y | Mol Divers | 2026 | 0 |